Spider Rock Advisors, LLC Vertex Pharmaceuticals Inc Put Options Transaction History

Spider Rock Advisors, LLC

  • $4.91 Billion
  • Q2 2024

Put Options

3 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2021

Oct 19, 2021
SELL
$181.39 - $202.99 $4.9 Million - $5.48 Million
-27,000 Closed
0 $0
Q2 2021

Aug 13, 2021
SELL
$187.49 - $221.1 $12.2 Million - $14.4 Million
-65,000 Reduced 70.65%
27,000 $5.27 Million
Q1 2021

May 12, 2021
BUY
$207.02 - $241.31 $19 Million - $22.2 Million
92,000 New
92,000 $19.6 Million

Others Institutions Holding VRTX

# of Institutions
1,707
Shares Held
226M
Call Options Held
1.2M
Put Options Held
1.59M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $123B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Spider Rock Advisors, LLC Portfolio

Follow Spider Rock Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spider Rock Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Spider Rock Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email